Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with α-cyclodextrin

被引:115
作者
Kihara, F [1 ]
Arima, H [1 ]
Tsutsumi, T [1 ]
Hirayama, F [1 ]
Uekama, K [1 ]
机构
[1] Kumamoto Univ, Fac Pharmaceut Sci, Kumamoto 8620973, Japan
关键词
D O I
10.1021/bc025557d
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To improve gene transfer activity of a new nonviral vector, a polyamidoamine dendrimer (G2) conjugate with (x-cyclodextrin (alpha-CDE conjugate (G2)), we prepared alpha-CDE conjugates with dendrimer having different generations (G3 and G4), and their gene transfer activities were compared with those of alpha-CDE conjugate (G2) and TransFast, a novel transfection reagent. a-CDE conjugates (G2, G3, and G4) formed the complexes with pDNA, changing the zeta-potential and particle size of pDNA complexes and the protection of pDNA from DNase I in a charge ratio-dependent manner, although their differences at higher charge ratios (vector/pDNA) were small. The gene transfer activity of a-CDE conjugates (G2, G3, and G4) was higher than that of the corresponding dendrimer alone in NIH3T3 and RAW264.7 cells. Of these CDE conjugates, alpha-CDE conjugate (G3) had a superior gene transfer activity which was comparable to that of TransFast in NIH3T3 cells. The intracellular distribution of pDNA after application of the pDNA complex with alpha-CDE conjugate (G3) to NIH3T3 cells was different from that with dendrimer alone (G3), although the cellular association of pDNA was almost comparable among all vectors. alpha-CDE conjugate (G3) strongly interacted with a fluorescence probe, 2-(p-toluidinyl)naphthalene-6-sulfonate (TNS), suggesting that the conjugate possesses the inclusion ability with biomembrane constituents such as phospholipids after transfection. These results suggest that a-CDE conjugates, particularly the G3 conjugate, could be novel nonviral gene transfer agents.
引用
收藏
页码:1211 / 1219
页数:9
相关论文
共 41 条
  • [1] Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence
    Abdou, S
    Collomb, J
    Sallas, F
    Marsura, A
    Finance, C
    [J]. ARCHIVES OF VIROLOGY, 1997, 142 (08) : 1585 - 1602
  • [2] Cyclodextrin derivatives in pharmaceutics
    Albers, E
    Muller, BW
    [J]. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1995, 12 (04): : 311 - 337
  • [3] Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclodextrins
    Arima, H
    Kihara, F
    Hirayama, F
    Uekama, K
    [J]. BIOCONJUGATE CHEMISTRY, 2001, 12 (04) : 476 - 484
  • [4] SERUM ALKALINE DNASE ACTIVITY IN NORMAL OR NONHOSPITALIZED INDIVIDUALS
    AVALLLUNDQVIST, E
    ECONOMIDOUKARAOGLOU, A
    SJOVALL, K
    LANS, M
    TAPER, HS
    ROBERFROID, M
    ENEROTH, P
    [J]. CLINICA CHIMICA ACTA, 1989, 185 (01) : 35 - 43
  • [5] Bender M.L., 1978, Cyclodextrin Chemistry
  • [6] Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers
    Bielinska, A
    KukowskaLatallo, JF
    Johnson, J
    Tomalia, DA
    Baker, JR
    [J]. NUCLEIC ACIDS RESEARCH, 1996, 24 (11) : 2176 - 2182
  • [7] Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine
    Croyle, MA
    Roessler, BJ
    Hsu, CP
    Sun, R
    Amidon, GL
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (09) : 1348 - 1355
  • [8] Vehicles for oligonucleotide delivery to tumours
    Dass, CR
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (01) : 3 - 27
  • [9] Cationic polymer based gene delivery systems
    De Smedt, SC
    Demeester, J
    Hennink, WE
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (02) : 113 - 126
  • [10] EICHMAN JD, 2000, PHARM SCI TECHNOL TO, V3, P32